Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
22 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
OBIPHAR from Frameries, company number BE0878100418, closed financial year 2025 with a result of € -1,220 after tax. For that financial year OBIPHAR recorded a gross margin of € 6,330 and equity of € 118,848. Compared with financial year 2024, the result moved from € 6,654 to € -1,220. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 118,848
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1,220
▼ still € 6,654 profit in 2024
Profit after tax over the fiscal year.
€ 118,717
▲ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 18,848.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 100,000
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 22,619 | € 7,307 | € 9,742 | € 6,330 | ▼ 35% |
| Profit after taxes | € 16,568 | € 4,862 | € 6,654 | € -1,220 | ▼ € 7,874 |
| Equity | € 148,552 | € 113,414 | € 120,068 | € 118,848 | ▼ 1% |
| Total debts | € 1,197 | € 40,000 | € 0 | € 100,000 | |
| Cash | € 149,722 | € 148,424 | € 115,316 | € 118,717 | ▲ 3% |
| Retained profit | € 48,552 | € 13,414 | € 20,068 | € 18,848 | ▼ 6% |
| Dividend | € 0 | € 40,000 | € 0 | € 0 | |
| Balance sheet total | € 149,749 | € 153,414 | € 120,068 | € 218,848 | ▲ 82% |
Key figures of OBIPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to OBIPHAR?
What happened at OBIPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- FINPHARMA stepped down as director. NBB
- GESTIPHARMA SA stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1,220 (▼ € 7,874 vs 2024). Source: NBB ↗
- FINPHARMA became a director. NBB
- GESTIPHARMA SA became a director. NBB
- New establishment in Frameries. KBO
- Start of the company according to the CBE. KBO
In short
From € 16,568 profit in 2022 to € 1,220 loss in 2025.
Paid € 9,360 in corporate taxes since 2022.
Best year ever: 2022, with € 16,568 profit.
Paid out € 40,000 in dividends to the owners in total.
A new publication or filing at OBIPHAR? We notify you, reason included.
Follow OBIPHARDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
since 2023 · until 2029
Managing director · represented by PIERRE PASCAL HECQ
Also active at: Les Pharmacies Réunies, Immobilière Général Léman, P.J. VLEUGELS et Cie, EVRAS, Les Pharmacies du Louvy, PHARMACIE CLAERHOUT, FARMIMMO, IMMOBILIERE SAINT GEORGES +12 more
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Rue Montavaux 155
7080 Frameries
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 22 companies are registered at this address.
All companies at this address →Les Pharmacies Réunies same network
€ 22,093 gross margin · 2025
Immobilière Général Léman same network
€ 92,019 gross margin · 2025
P.J. VLEUGELS et Cie same network
€ 132,509 gross margin · 2025
EVRAS same network
€ 47,127 gross margin · 2025
Pharmacie Grenez - Seeuws
€ 16,802 gross margin · 2025
+17 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0878.100.418
- VAT number
- BE 0878.100.418
- Registered office
- Rue Montavaux 155, 7080 Frameries
- Names & denominations
- OBIPHAR
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 December 2005
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers